DK0521787T3 - Vanadiumkomplekser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem - Google Patents

Vanadiumkomplekser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem

Info

Publication number
DK0521787T3
DK0521787T3 DK92401883.1T DK92401883T DK0521787T3 DK 0521787 T3 DK0521787 T3 DK 0521787T3 DK 92401883 T DK92401883 T DK 92401883T DK 0521787 T3 DK0521787 T3 DK 0521787T3
Authority
DK
Denmark
Prior art keywords
alkyl
chemical structure
hydroxyl
formula
processes
Prior art date
Application number
DK92401883.1T
Other languages
Danish (da)
English (en)
Inventor
Jean-Michel Lacoste
Jacques Duhault
Denis Ravel
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0521787T3 publication Critical patent/DK0521787T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/005—Compounds of elements of Group 5 of the Periodic Table without metal-carbon linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK92401883.1T 1991-07-03 1992-07-02 Vanadiumkomplekser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem DK0521787T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR919108253A FR2678622B1 (fr) 1991-07-03 1991-07-03 Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
DK0521787T3 true DK0521787T3 (da) 1997-10-27

Family

ID=9414615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92401883.1T DK0521787T3 (da) 1991-07-03 1992-07-02 Vanadiumkomplekser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem

Country Status (14)

Country Link
US (2) US5266565A (de)
EP (1) EP0521787B1 (de)
JP (1) JPH0742302B2 (de)
AT (1) ATE152113T1 (de)
AU (1) AU649849B2 (de)
CA (1) CA2072938A1 (de)
DE (1) DE69219221T2 (de)
DK (1) DK0521787T3 (de)
ES (1) ES2102478T3 (de)
FR (1) FR2678622B1 (de)
GR (1) GR3023940T3 (de)
IE (1) IE922160A1 (de)
NZ (1) NZ243418A (de)
ZA (1) ZA924966B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637739A (en) * 1990-03-21 1997-06-10 Research Corporation Technologies, Inc. Chiral catalysts and catalytic epoxidation catalyzed thereby
US6211107B1 (en) 1994-02-04 2001-04-03 Smithkline Beecham P.L.C. Process for expoxidizing prochiral olefins and a catalyst therefor and intermediates for making the catalyst
ATE263770T1 (de) * 1994-02-04 2004-04-15 Smithkline Beecham Plc Verfahren zum epoxidieren prochiral olefine
US20020132326A1 (en) * 1995-12-15 2002-09-19 Hemmings Brian A. Process for activating a kinase
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
GB9525703D0 (en) * 1995-12-15 1996-02-14 Ciba Geigy Ag Screening method
US5955111A (en) * 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
US5986136A (en) * 1997-04-15 1999-11-16 President And Fellows Of Harvard College Photolabeling reagent
US6232340B1 (en) 1997-04-24 2001-05-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
WO1998049173A1 (en) * 1997-04-24 1998-11-05 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
WO2000024730A1 (en) * 1998-10-28 2000-05-04 The University Of British Columbia Organic vanadium(iii) complexes and their use
EP1169322B8 (de) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
EP1196171A2 (de) 1999-07-13 2002-04-17 Medicure Inc. Verwendung der pyridoxin-derivaten zur behandlung von diabetes und komplikationen davon
EP1210117A2 (de) * 1999-08-24 2002-06-05 Medicure International Inc. Zusammensetzungen zur behandlung von kardiovaskularen krankheiten die pyridoxal-derivate und kardiovaskuläre mittel enthalten
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
DE60133323T2 (de) 2000-02-29 2009-03-05 Medicure International Inc. Cardioprotektive Phosphonate
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US6957781B2 (en) * 2003-09-15 2005-10-25 Kraft Food Holdings, Inc. Cleaning attachment for fluid dispenser nozzles and fluid dispensers using same
CN101014357A (zh) * 2004-07-07 2007-08-08 麦迪库瑞国际公司 利用血小板聚集药物的组合疗法
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
EP1817288A4 (de) * 2004-10-28 2009-08-26 Medicure Int Inc Duale antiplättchen-/antikoagulans-pyridoxinanaloge
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤
KR100722795B1 (ko) 2005-12-26 2007-05-30 한국조폐공사 초근적외선을 흡수하는 이소인돌린 비대칭 사량체환 화합물및 이를 이용한 제품
GB0607096D0 (en) * 2006-04-07 2006-05-17 Imp Innovations Ltd Compound
PL231079B1 (pl) 2012-11-07 2019-01-31 Univ Jagiellonski Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami
JP6735163B2 (ja) * 2016-06-22 2020-08-05 株式会社Adeka バナジウム化合物、薄膜形成用原料及び薄膜の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2619382B1 (fr) * 1987-08-11 1990-05-04 Lazaro Rene Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral

Also Published As

Publication number Publication date
AU649849B2 (en) 1994-06-02
US5278154A (en) 1994-01-11
FR2678622A1 (fr) 1993-01-08
US5266565A (en) 1993-11-30
IE922160A1 (en) 1993-01-13
AU1941392A (en) 1993-01-07
EP0521787A1 (de) 1993-01-07
ATE152113T1 (de) 1997-05-15
DE69219221T2 (de) 1997-11-20
FR2678622B1 (fr) 1994-11-18
DE69219221D1 (de) 1997-05-28
NZ243418A (en) 1994-04-27
EP0521787B1 (de) 1997-04-23
ES2102478T3 (es) 1997-08-01
JPH05186481A (ja) 1993-07-27
GR3023940T3 (en) 1997-09-30
ZA924966B (en) 1993-03-31
CA2072938A1 (fr) 1993-01-04
JPH0742302B2 (ja) 1995-05-10

Similar Documents

Publication Publication Date Title
DK0521787T3 (da) Vanadiumkomplekser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2079453T3 (es) Mejoras en compuestos quimicos.
ES8605806A1 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
MXPA02003199A (es) Derivados de sulfonamida farmaceuticamente activos.
FI954105A (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
WO2002059102A3 (fr) Derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et utilisation
DE69312984D1 (de) Substituierte Aminophosphonatderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DK570689A (da) Imidazolderivater
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
DK0452204T3 (da) Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0486385T3 (da) Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0635495T3 (da) Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
EP0641763A4 (de) Neue quaternäre ammoniumsalze und deren medizinische verwendung.
EA200300029A1 (ru) Новые соединения карбамат и тиокарбамат подофиллотоксина, способ их получения и содержащие их фармацевтические композиции
DK0390138T3 (da) Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel
EA200000527A2 (ru) Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их
IL100915A0 (en) Disubstituted ureas and thioureas,their preparation and pharmaceutical compositions containing them
ATE93524T1 (de) Mitomycinanaloge, verfahren zu ihrer herstellung und pharmazeutische zubereitungen.
ATE97898T1 (de) Antitumor-substanz, verfahren zu deren herstellung und diese enthaltende antikrebsmittel.
HU9402171D0 (en) Benzopyrane derivatives process for producing them, and pharmaceutical compositions containing them
TH2508EX (th) 9-อะมิโนแอลคิลฟลูออรีน
MY103577A (en) New aminoacylates of glycerol acetal
TH17758EX (th) สารเคมี
TH18165A (th) สารยับยั้งการเกิดคีโมแทกซิของอีโอซีโนฟีล